Patent · US Active

Single use system for sterilely producing lipid-nucleic acid particles

US8956572B2 · kind B2 · utility

6Cited by
18References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2012
Grant dateFeb 17, 2015
Priority date—
Expiry dateNov 5, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

What is described is a process of forming lipid-nucleic acid nanoparticles simply and reproducibly under aseptic conditions comprising single use components.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.